6533b856fe1ef96bd12b2bf5
RESEARCH PRODUCT
Fasting and postprandial effects of rosiglitazone on low- and high-density lipoproteins size and subclasses in type-2 diabetes.
Manfredi RizzoK BerneisJ VekicGb RiniS KoulourisD SakellariouS PastromasAs Manolissubject
diabetes| year | journal | country | edition | language | 
|---|---|---|---|---|
| 2010-01-01 |